Cost-Effectiveness of Proton Therapy Compared With Photon Therapy in Breast Cancer
Findings from this economic evaluation of proton therapy for breast cancer suggest that proton therapy is unlikely to be cost-effective for most Belgian patients under current cost conditions, except for a small subset of high-risk patients, especially when DIBH is available.
Authors
- Eva Kimpe (ORCID: https://orcid.org/0009-0002-9061-8914)
- Thierry Gevaert (ORCID: https://orcid.org/0000-0003-4556-5681)
- Sara-Lise Busschaert (ORCID: https://orcid.org/0000-0003-0248-9164)
- Koen Putman
- Mark De Ridder
Institutions
- Vrije Universiteit Brussel (BE)
- Universitair Ziekenhuis Brussel (BE)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.54888
- Primary Topic
- Advances in Oncology and Radiotherapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Vrije Universiteit Brussel
- Kom op tegen Kanker